RBC keeps St. Jude sector perform rating

St. Jude Medical, Inc. was maintained at a sector perform, average risk, rating and $46 price target by RBC Capital Markets analyst Phil Nalbone after the company turned in a disappointing third-quarter financial performance, marked by even weaker-than-expected sales of ICDs. The company had revenue growth of 11% to $821.3 million, falling short of the analyst's estimate of $822.8 million, closer to the consensus Street estimate of $821.2 million. ICD sales of $271 million, were $17 million below RBC's estimate of $288 million. Shares of the St. Paul, Minn.-based medical device company were down $1.54, or 4.13%, at $35.73. (NYSE: STJ)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.